CFL1 and congenital rubella syndrome: The group of Hsing-Yu Chen et al. [73] measured cofilin-1 in 44 patients: 13 patients were diagnosed with CRS, while the other 31 patients were classified into a non-CRS group; they predicted the occurrence of CRS and differentiated CRS patients from non-CRS patients, using the gold nanoparticle-based localized surface plasmon-coupled fluorescence biosensor with a significant accuracy (p = 0.031; overall accuracy 79.55%).